AAF
RPRX icon

Andra AP-fonden’s Royalty Pharma RPRX Stock Holding History

Andra AP-fonden’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.51M Buy
+177,500
New +$7.77M 0.1% 223
2024
Q1 		– Sell
-198,700
Closed -$5.58M – 428
2023
Q4 		$5.58M Buy
198,700
+40,500
+26% +$1.11M 0.3% 158
2023
Q3 		$4.29M Buy
158,200
+5,500
+4% +$163K 0.25% 192
2023
Q2 		$4.69M Buy
152,700
+42,100
+38% +$1.43M 0.12% 405
2023
Q1 		$3.98M Sell
110,600
-41,200
-27% -$1.53M 0.1% 422
2022
Q4 		$6M Sell
151,800
-18,400
-11% -$768K 0.18% 251
2022
Q3 		$6.84M Buy
170,200
+30,900
+22% +$1.32M 0.22% 175
2022
Q2 		$5.86M Buy
+139,300
New +$5.71M 0.17% 272
2021
Q4 		$5.67M Sell
142,300
-16,300
-10% -$633K 0.12% 391
2021
Q3 		$5.73M Buy
158,600
+28,500
+22% +$1.11M 0.12% 389
2021
Q2 		$5.33M Buy
130,100
+29,800
+30% +$1.27M 0.11% 426
2021
Q1 		$4.38M Sell
100,300
-16,500
-14% -$782K 0.1% 459
2020
Q4 		$5.85M Buy
+116,800
New +$4.96M 0.13% 392

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Andra AP-fonden's RPRX Position: Q1 2026 in Review

Andra AP-fonden opened a new position in Royalty Pharma (RPRX) in Q1 2026: 177,500 shares worth $8.51M. The stake represents 0.1% of the portfolio and ranks #223 among its holdings. This is a return to the name: Andra AP-fonden previously reported a position in RPRX as recently as Q4 2023.

Andra AP-fonden first reported a position in RPRX in Q4 2020 and has held it in 13 quarters since. 592 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Andra AP-fonden held 177,500 shares of Royalty Pharma worth $8.51M as of Q1 2026.
  • Royalty Pharma was a new Andra AP-fonden position in Q1 2026.
  • Royalty Pharma made up 0.1% of Andra AP-fonden's portfolio in Q1 2026, its #223 holding.
  • Andra AP-fonden first reported a position in Royalty Pharma in Q4 2020 and has held it in 13 quarters since.
  • 592 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.